Lamotrigine 1-mg/mL Oral Suspension
Download in electronic PDF format for $75
Abstract: A formulation for preparing Lamotrigine 1-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
lamotrigine, anticonvulsant agent, seizure disorders, bipolar disorder
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Lamotrigine 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 223
|
Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 148
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Lamotrigine 1 mg/mL in SuspendIt Plus
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 323
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Lamotrigine 25-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 156
|
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
|
Mar/Apr 2016
Pg. 167-174
|
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A, Fokken Dawn
|
Sep/Oct 2009
Pg. 386-389
|
Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 340
|
Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 229
|
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 486
|
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 502
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 487
|
Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
|
Jul/Aug 2011
Pg. 302-307
|
Enalapril Maleate 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 221
|
Attention Deficit Hyperactivity Disorder
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 87-89
|
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 342
|
| Return to Top |
